Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Ciforadenant by Corvus Pharmaceuticals for Uterine Cancer: Likelihood of Approval
Ciforadenant is under clinical development by Corvus Pharmaceuticals and currently in Phase II for Uterine Cancer. According to GlobalData, Phase...
Ciforadenant by Corvus Pharmaceuticals for Endometrial Cancer: Likelihood of Approval
Ciforadenant is under clinical development by Corvus Pharmaceuticals and currently in Phase II for Endometrial Cancer. According to GlobalData, Phase...
Ciforadenant by Corvus Pharmaceuticals for Sarcomas: Likelihood of Approval
Ciforadenant is under clinical development by Corvus Pharmaceuticals and currently in Phase II for Sarcomas. According to GlobalData, Phase II...
Ciforadenant by Corvus Pharmaceuticals for Cervical Cancer: Likelihood of Approval
Ciforadenant is under clinical development by Corvus Pharmaceuticals and currently in Phase II for Cervical Cancer. According to GlobalData, Phase...
Ciforadenant by Corvus Pharmaceuticals for Metastatic Renal Cell Carcinoma: Likelihood of Approval
Ciforadenant is under clinical development by Corvus Pharmaceuticals and currently in Phase II for Metastatic Renal Cell Carcinoma. According to...